Mega Genomics Limited (HKG:6667)
Hong Kong · Delayed Price · Currency is HKD 6.99
+0.03 (0.43%)
At close: Mar 6, 2026
Mega Genomics Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 35.34 | 45.05 | 30.04 | -17.62 | 79.02 | 79.1 |
Depreciation & Amortization | 14.8 | 14.51 | 14.97 | 15.12 | 13.77 | 13.94 |
Other Amortization | 0.16 | 0.16 | 0.16 | 0.16 | 0.11 | 0.09 |
Loss (Gain) From Sale of Investments | -1.2 | -1.2 | 0.43 | 0.17 | -0.06 | -0.1 |
Stock-Based Compensation | 1.21 | 2.42 | 7.29 | 4.95 | - | - |
Provision & Write-off of Bad Debts | -3.97 | -7.92 | -13.98 | 25.85 | 6.17 | -0.73 |
Other Operating Activities | -4.76 | -0.04 | -1.62 | -29.47 | 10.13 | 18.66 |
Change in Accounts Receivable | 62.42 | 33.74 | 82.92 | -7.05 | -79.56 | -21.38 |
Change in Inventory | -4.14 | -0.2 | -0.9 | -0.22 | -0.31 | -0.53 |
Change in Accounts Payable | -22.88 | -14.11 | 4.78 | 5.56 | 2.31 | 14.88 |
Change in Unearned Revenue | -3.65 | -3.65 | 42.41 | - | - | - |
Change in Other Net Operating Assets | -32.43 | -11.62 | -2.81 | -4.36 | -0.94 | -1.1 |
Operating Cash Flow | 40.89 | 57.15 | 163.68 | -6.91 | 30.63 | 102.84 |
Operating Cash Flow Growth | -63.28% | -65.09% | - | - | -70.22% | 175.91% |
Capital Expenditures | -0.25 | -0.76 | -35.86 | -5.01 | -4.16 | -1.05 |
Sale (Purchase) of Intangibles | - | -0.01 | -0.24 | -0.18 | -0.26 | - |
Investment in Securities | 4.97 | 7.4 | 2.34 | 2.63 | 2.71 | -30.04 |
Investing Cash Flow | 4.72 | 6.63 | -33.75 | -2.56 | -1.71 | -31.09 |
Long-Term Debt Issued | - | - | 23.56 | - | - | - |
Long-Term Debt Repaid | - | -12.52 | -9.35 | -7.32 | -10.59 | -14.09 |
Net Debt Issued (Repaid) | -6.36 | -12.52 | 14.21 | -7.32 | -10.59 | -14.09 |
Issuance of Common Stock | - | - | - | 184.16 | 228.82 | 100 |
Repurchase of Common Stock | -87.59 | -77.62 | -26 | - | -214.14 | - |
Other Financing Activities | -1.31 | -1.72 | -1.12 | -18.38 | -1.47 | -1.85 |
Financing Cash Flow | -95.26 | -91.85 | -12.91 | 158.46 | 2.62 | 84.06 |
Foreign Exchange Rate Adjustments | 0.17 | 0.04 | 1.44 | 11.75 | -0.89 | - |
Net Cash Flow | -49.48 | -28.03 | 118.46 | 160.74 | 30.65 | 155.8 |
Free Cash Flow | 40.64 | 56.39 | 127.83 | -11.92 | 26.47 | 101.79 |
Free Cash Flow Growth | -53.57% | -55.89% | - | - | -74.00% | 177.43% |
Free Cash Flow Margin | 29.40% | 34.34% | 84.49% | -8.18% | 11.16% | 50.09% |
Free Cash Flow Per Share | 0.20 | 0.27 | 0.60 | -0.06 | 0.21 | - |
Cash Interest Paid | 1.31 | 1.72 | 1.12 | 0.72 | 0.79 | 1.85 |
Cash Income Tax Paid | 8.75 | 5.32 | 3.9 | 11.26 | 10.62 | 13.09 |
Levered Free Cash Flow | 29.61 | 41.23 | 98.38 | 22.72 | -193.51 | 260 |
Unlevered Free Cash Flow | 30.43 | 42.31 | 99.08 | 23.17 | -189.19 | 270.34 |
Change in Working Capital | -0.69 | 4.17 | 126.4 | -6.07 | -78.5 | -8.14 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.